Fig. 1
From: How to use CT texture analysis for prognostication of non-small cell lung cancer
The potential for prognostic biomarkers to stratify care for patients with NSCLC. CT showing left upper lobe NSCLC at initial staging a. Based on current practice, the patient underwent surgery without adjuvant chemotherapy. CT performed 25Â months later shows local recurrence b. A biomarker deployed at staging may have categorised the patient as high-risk for recurrence, implying a potential benefit from adjuvant chemotherapy